141 related articles for article (PubMed ID: 21079805)
1. In vitro HIV-1 selective integration into the target sequence and decoy-effect of the modified sequence.
Tsuruyama T; Nakai T; Hiratsuka T; Jin G; Nakamura T; Yoshikawa K
PLoS One; 2010 Nov; 5(11):e13841. PubMed ID: 21079805
[TBL] [Abstract][Full Text] [Related]
2. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
[TBL] [Abstract][Full Text] [Related]
3. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
[TBL] [Abstract][Full Text] [Related]
4. Mapping of HIV-1 integrase preferences for target site selection with various oligonucleotides.
Snásel J; Rosenberg I; Paces O; Pichová I
Arch Biochem Biophys; 2009 Aug; 488(2):153-62. PubMed ID: 19549503
[TBL] [Abstract][Full Text] [Related]
5. In vitro HIV-1 LTR integration into T-cell activation gene CD27 segment and the decoy effect of modified-sequence DNA.
Ohmori R; Tsuruyama T
PLoS One; 2012; 7(11):e49960. PubMed ID: 23209625
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
Sinha S; Grandgenett DP
J Virol; 2005 Jul; 79(13):8208-16. PubMed ID: 15956566
[TBL] [Abstract][Full Text] [Related]
8. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
9. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
10. Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase.
Delelis O; Parissi V; Leh H; Mbemba G; Petit C; Sonigo P; Deprez E; Mouscadet JF
PLoS One; 2007 Jul; 2(7):e608. PubMed ID: 17622353
[TBL] [Abstract][Full Text] [Related]
11. Triplex-mediated inhibition of HIV DNA integration in vitro.
Mouscadet JF; Carteau S; Goulaouic H; Subra F; Auclair C
J Biol Chem; 1994 Aug; 269(34):21635-8. PubMed ID: 8063805
[TBL] [Abstract][Full Text] [Related]
12. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
13. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
14. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.
Varadarajan J; McWilliams MJ; Hughes SH
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14747-52. PubMed ID: 23959861
[TBL] [Abstract][Full Text] [Related]
15. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites.
Tan W; Zhu K; Segal DJ; Barbas CF; Chow SA
J Virol; 2004 Feb; 78(3):1301-13. PubMed ID: 14722285
[TBL] [Abstract][Full Text] [Related]
16. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
17. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
Leavitt AD; Rose RB; Varmus HE
J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
[TBL] [Abstract][Full Text] [Related]
18. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
Esposito D; Craigie R
EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
[TBL] [Abstract][Full Text] [Related]
19. Displacement of viral DNA termini from stable HIV-1 integrase nucleoprotein complexes induced by secondary DNA-binding interactions.
Pemberton IK; Buc H; Buckle M
Biochemistry; 1998 Feb; 37(8):2682-90. PubMed ID: 9485419
[TBL] [Abstract][Full Text] [Related]
20. The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.
Pandey KK; Bera S; Grandgenett DP
Biochemistry; 2011 Nov; 50(45):9788-96. PubMed ID: 21992419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
